Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 17 von 319
Cancer and metastasis reviews, 2018-09, Vol.37 (2-3), p.245-255
2018
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
The role of lipid signaling in the progression of malignant melanoma
Ist Teil von
  • Cancer and metastasis reviews, 2018-09, Vol.37 (2-3), p.245-255
Ort / Verlag
New York: Springer US
Erscheinungsjahr
2018
Quelle
MEDLINE
Beschreibungen/Notizen
  • In the past decades, a vast amount of data accumulated on the role of lipid signaling pathways in the progression of malignant melanoma, the most metastatic/aggressive human cancer type. Genomic studies identified that PTEN loss is the leading factor behind the activation of the PI3K-signaling pathway in melanoma, mutations of which are one of the main resistance mechanisms behind target therapy failures. On the other hand, illegitimate expressions of megakaryocytic genes p12-lipoxyganse, cyclooxygenase-2, and phosphodiestherase-2/autotaxin (ATX) are mostly involved in the regulation of motility signaling in melanoma through various G-protein-coupled bioactive lipid receptors. Furthermore, endocannabinoid signaling can also be a novel paracrine survival factor in melanoma. Last but not least, prenylation inhibitors acting even on mutated small GTP-ases, such as NRAS of melanoma may offer novel therapeutic opportunities. As regards melanoma, the most effective therapy nowadays is immunotherapy, with the resistance mechanisms also possibly involving the lipid signaling activities of melanoma cells, which further supports the idea of their being therapeutic targets.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX